PL355106A1 - Nowy dyspergowalny i rozpuszczalny preparat galenowy paracetamolu, sposób jego otrzymywania i jego zastosowania - Google Patents

Nowy dyspergowalny i rozpuszczalny preparat galenowy paracetamolu, sposób jego otrzymywania i jego zastosowania

Info

Publication number
PL355106A1
PL355106A1 PL01355106A PL35510601A PL355106A1 PL 355106 A1 PL355106 A1 PL 355106A1 PL 01355106 A PL01355106 A PL 01355106A PL 35510601 A PL35510601 A PL 35510601A PL 355106 A1 PL355106 A1 PL 355106A1
Authority
PL
Poland
Prior art keywords
soluble
dispersible
galenic
paracetamol
applications
Prior art date
Application number
PL01355106A
Other languages
English (en)
Inventor
Martin Luis Carvajal
Asensio Juan Carlos Asensio
Tirado Francisco Javier Sevilla
Original Assignee
Laboratorios Belmac, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Belmac, S.A. filed Critical Laboratorios Belmac, S.A.
Publication of PL355106A1 publication Critical patent/PL355106A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL01355106A 2000-11-03 2001-10-24 Nowy dyspergowalny i rozpuszczalny preparat galenowy paracetamolu, sposób jego otrzymywania i jego zastosowania PL355106A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200002653A ES2174734B1 (es) 2000-11-03 2000-11-03 Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
PCT/ES2001/000402 WO2002036101A1 (es) 2000-11-03 2001-10-24 Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones

Publications (1)

Publication Number Publication Date
PL355106A1 true PL355106A1 (pl) 2004-04-05

Family

ID=8495530

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01355106A PL355106A1 (pl) 2000-11-03 2001-10-24 Nowy dyspergowalny i rozpuszczalny preparat galenowy paracetamolu, sposób jego otrzymywania i jego zastosowania

Country Status (9)

Country Link
US (1) US6620433B2 (pl)
EP (1) EP1331001B1 (pl)
JP (1) JP2004512355A (pl)
AT (1) ATE271378T1 (pl)
DE (1) DE60104442T2 (pl)
ES (1) ES2174734B1 (pl)
PL (1) PL355106A1 (pl)
PT (1) PT1331001E (pl)
WO (1) WO2002036101A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114069D0 (en) 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US6581767B2 (en) * 2001-08-20 2003-06-24 Wen-Chien Cheng Golf bag base
AU2004234176B2 (en) * 2003-05-02 2010-05-13 Globopharm Pharmazeutische Produktions- Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP3263117A1 (en) * 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
KR101465647B1 (ko) * 2013-02-25 2014-11-27 김성호 가용성 타블렛형 청즙차의 제조방법
KR101881074B1 (ko) * 2013-11-13 2018-08-17 내셔널 디펜스 에듀케이션 앤드 리서치 파운데이션 간에 대한 부작용이 없는 신규의 아세트아미노펜 화합물 조성물
EP2987482A1 (en) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Soluble and dispersible pharamaceutical deferasirox formulation
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092893B1 (pl) * 1970-06-29 1973-07-13 Bru Jean
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
CA1209040A (fr) 1982-12-21 1986-08-05 Jean Bru Procede de fabrication de granules et comprimes effervescents
US4942039A (en) 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
ES2060736T3 (es) * 1989-01-12 1994-12-01 Bayer Ag Composicion antiacida analgesica efervescente con un contenido en sodio reducido.
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
DE69817189T2 (de) * 1998-11-23 2004-06-17 E-Pharma Trento S.P.A., Trento Ravina Verfahren zur Herstellung eines Brausegranulats
US6544557B2 (en) * 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions

Also Published As

Publication number Publication date
US6620433B2 (en) 2003-09-16
WO2002036101A1 (es) 2002-05-10
PT1331001E (pt) 2004-11-30
JP2004512355A (ja) 2004-04-22
DE60104442D1 (de) 2004-08-26
DE60104442T2 (de) 2005-09-15
US20020197312A1 (en) 2002-12-26
ES2174734B1 (es) 2003-10-01
ATE271378T1 (de) 2004-08-15
EP1331001A1 (en) 2003-07-30
ES2174734A1 (es) 2002-11-01
EP1331001B1 (en) 2004-07-21

Similar Documents

Publication Publication Date Title
EG20401A (en) Process for preparing of veterinary composition for the treatment of gastric acid related deseases in animals
CA2396159A1 (en) Novel substituted benzimidazole dosage forms and method of using same
DK455286A (da) Farmaceutisk middel med langsom frigoering og fremgangsmaade til dets fremstilling
WO2001078725A3 (en) Modified release formulations containing a hypnotic agent
HUP0103494A3 (en) Process for intermittent administration use of growth hormone secretagogues for the manufacture of pharmaceutical compositions for intermittent administration and kit comprising thereof
NO870181L (no) Fremgangsmaate for fremstilling av et fast farmasoeytisk preparat med forsinket frigjoering.
SI1341524T1 (sl) Farmacevtski pripravek v obliki paste, ki obsega kislinsko labilno učinkovino
DK0673245T3 (da) Farmaceutisk brusepræparat indeholdende ibuprofen og fremgangsmåde til dets fremstilling.
PL355106A1 (pl) Nowy dyspergowalny i rozpuszczalny preparat galenowy paracetamolu, sposób jego otrzymywania i jego zastosowania
IL150528A0 (en) Ibuprofen containing active agent preparation
MY128896A (en) Pharmaceutical combinations
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
HRP20030762A2 (en) A stable pharmaceutical formulation comprising torsemide modofication ii
ID26240A (id) Formulasi obat setengah padat yang mengandung dekstoprofen trometamol
DE50201005D1 (de) Verfahren zur herstellung von tabletten aus pflanzlichen extrakten
DE60123447D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe
JPS5344617A (en) Drug composition
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS
DE60121142D1 (de) Zusammensetzung die paracetamol und niflumic säure enthält
NZ532449A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and Crohn's disease
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
UA83094C2 (en) Tablet of citalopram hydrobromide
TH43075A (th) สารผสมตามสูตรที่ควบคุมการปลดปล่อยสำหรับการรักษา copd

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)